Time-dependence of hazard ratios for prognostic factors in primary breast cancer

Breast Cancer Research and Treatment

Volumn 52, Issue 1-3, 1998, Pages 227-237

  Hilsenbeck, Susan G ^a,b   Ravdin, Peter M ^a   De Moor, Carl A ^a   Chamness, Gary C ^a   Osborne, C Kent ^a   Clark, Gary M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Breast cancer; Cox models; Nonproportional hazards; Prognostic factors

Indexed keywords

ESTROGEN RECEPTOR; PROTEIN P53;

AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CELL CYCLE S PHASE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, ESTROGEN; S PHASE; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032443067     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006133418245     Document Type: Review

References (25)

1. Knight WA III, Livingston RB, Gregory EJ, McGuire WL: Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37:4669-4671, 1977
2. Raemaekers JMM, Beex LVAM, Koenders AJM, Pieters GFFM, Smals AGH, Benraad TJ, Kloppenborg PWC, The Breast Cancer Group: Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up. Breast Cancer Res Treat 6:123-130, 1985
3. Andry G, Suciu S, Pratola D, Sylvester R, Leclercq G, Mendes de Costa P, Legros N, Andry-T'Hoot M, Verhest A, Mattheim W, Heuson J-C: Relation between estrogen receptor concentration and clinical and histological factors: Their relative prognostic importance after radical mastectomy for primary breast cancer. Eur J Cancer Clin Oncol 25:319-329, 1989
4. Cox DR: Regression models and life-tables (with discussion). J R Statist Soc B 34:187-200, 1972
5. Gray RJ: Flexible methods for analyzing survival data using splines, with application to breast cancer prognosis. J Am Statist Assoc 87:942-951, 1992
6. Gray RJ: Spline-based tests in survival analysis. Biometrics 50:640-652, 1994
7. Clark GM, Dressler LG, Owens MA, Pounds G, Oldaker T, McGuire WL: Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med 320:627-633, 1989
8. McGuire WL, De La Garza M, Chamness GC: Evaluation of estrogen receptor assays in human breast cancer tissue. Cancer Res 37:637-639, 1977
9. Powell B, Garola RE, Chamness GC, McGuire WL: Measurement of progesterone receptor in human breast cancer biopsies. Cancer Res 39:1678-1682, 1979
10. Dressler LG, Seamer LC, Owens MA, Clark GM, McGuire WL: DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 61:420-427, 1988
11. Wenger CR, Beardslee S, Owens MA, Pounds G, Oldaker T, Vendely P, Pandian MR, Harrington D, Clark GM, McGuire WL: DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients. Breast Cancer Res Treat 28:9-20, 1993
12. Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC, Osborne CK, McGuire WL: Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 85:200-206, 1993
13. Allred DC, Clark GM, Tandon AK, McGuire WL: Immunohistochemistry on histological sections from small (50 mg) samples of pulverized breast cancer. J Histotech 16:117-120, 1993
14. Grambsch PM, Therneau TM: Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515-526, 1994
15. Schoenfeld D: Chi-squared goodness of fit tests for the proportional hazards regression model. Biometrika 67:145-153, 1980
16. Statistical Sciences: S-PLUS Version 3.3 Supplement. StatSci (a division of MathSoft, Inc.), Seattle, 1995
17. Hess KR: Graphical methods for assessing violations of the proportional hazards assumptions in Cox regression. Stat Med 14:1707-1723, 1995
18. Therneau T: SURVIVAL4.1 available through Stat-Lib (http://lib.stat.cmu.edu/). Mayo Foundation for Education and Research, Rochester MN, 1994
19. Altman DG, De Stavola BL, Love SB, Stepniewska KA: Review of survival analyses published in cancer journals. Br J Cancer 72:511-518, 1995
20. Concato J, Feinstein AR, Holford TR: The risk of determining risk with multivariable models. Ann Int Med 118:201-210, 1993
21. Gore SM, Pocock SJ, Kerr GR: Regression models and non-proportional hazards in the analysis of breast cancer survival. Appl Statist 33:176-195, 1984
22. Ulm K, Jänicke F, Pache L, Dannegger F: Change in prognostic impact of uPA and PAI-1 in node-negative breast cancer patients during the follow-up. Breast Cancer Res Treat 37(S):59, 1996
23. Wei LJ: The accelerated failure time model: a useful alternative to the Cox regression model in survival analysis. Stat Med 11:1871-1879, 1992
24. Bennett S: Log-logistic regression models for survival data. Appl Statist 32:165-171, 1983
25. Collett D: Modelling Survival Data in Medical Research. Chapman & Hall, New York, 1994